Company intelligence / Profile preview

Zinzino

Gothenburg, Swedenzinzino.com ↗
Ownership
Private
Development stage
Commercial
01

Overview

Zinzino offers a commercial portfolio of scientifically validated, test-based nutritional supplements and biotech skincare products. Their approach includes home blood tests for personalized nutrition recommendations. The company reports strong revenue growth and global expansion, but does not conduct traditional drug clinical trials[4][5][6].

Therapeutic areas
OtherDermatologyImmunologyGastroenterology
Modalities
Nutritional supplementBiologicDevice
Industry
Food & Nutrition
02

Drug pipeline

2 assets

BalanceOil+

Commercial
Indications
Omega-3 deficiency

1 more asset in the full pipeline.

03

Partnerships

Collaboration with world leader in dried blood spot testing for lab analysis of home tests

Beyond the preview

Go deeper on Zinzino.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinzino.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call